Post

Product Labeling Requirements for Laparoscopic Power Morcellators in Gynecologic Surgery

This guidance provides recommendations for labeling information of Laparoscopic Power Morcellators (LPMs) used in gynecologic surgeries, regardless of their morcellation mechanism. It applies to LPMs with either general or specific gynecologic indications but excludes those specifically indicated only for non-gynecologic surgery and hysteroscopic morcellators.

  1. Update device labeling to include the required boxed warning
  2. Implement all specified contraindications in the labeling
  3. Add all required warnings regarding age-related risks
  4. Include information about containment system requirements
  5. Submit both current and revised labeling to CDRH
  6. Provide updated labeling to existing device purchasers
  7. Ensure compatibility with appropriate containment systems
  8. Include information about the risks of spreading both malignant and benign tissue
  9. Update physician and patient information materials to reflect all new labeling requirements
  10. Submit labeling changes as an “add-to-file” to existing 510(k) clearances

Key Considerations

Labelling

  • Must include a boxed warning about the risk of spreading unsuspected cancer
  • Must include specific contraindications for use in known/suspected malignancy cases
  • Must include contraindications for specific patient populations (post-menopausal, over 50 years)
  • Must include warnings about increased cancer risk with age
  • Must include warnings about spread of benign tissue
  • Must include information about containment system requirements

Safety

  • Must be used with a compatible containment system
  • Should not be used in cases of known or suspected malignancy
  • Should not be used in patients who are candidates for en bloc tissue removal

Other considerations

  • 21 CFR 884.4050: Gynecologic laparoscopic power morcellation containment system

Original guidance

  • Product Labeling Requirements for Laparoscopic Power Morcellators in Gynecologic Surgery
  • HTML / PDF
  • Issue date: 2020-12-30
  • Last changed date: 2020-12-29
  • Status: FINAL
  • Official FDA topics: Medical Devices, Errors, Obstetrical & Gynecological, Postmarket, and Problems, General & Plastic Surgery, 510(k), Labeling, Premarket, Safety - Issues
  • ReguVirta summary file ID: 4940a64845fb5c0e737c401f8d202b51
This post is licensed under CC BY 4.0 by the author.